Literature DB >> 8778974

Implementation of the rhesus prevention programme: a prospective study.

S Ghosh1, W G Murphy.   

Abstract

All rhesus-negative women who completed a pregnancy between January and August 1992 in two Scottish regions were studied to assess whether the administration of the rhesus prevention programme was complete: 671 rhesus positive (or rhesus type unknown) pregnancies were completed in 1120 Rh D negative women. For eight pregnancies no record of Rh D administration at birth was available. For recorded antenatal events that should have resulted in its administration anti-D was given in 195/280 (69.6%). Kleihauer testing was carried out in 9 of 98 instances of antepartum haemorrhage occurring after 20 weeks gestation. No cases of antenatal immunisation were identified. The study identified a need to increase awareness of the necessity for anti-D administration after potentially immunising events during pregnancy, and for increasing compliance with administration of postnatal anti-D in one of the study regions. Re-evaluation is also required of the recommendation that Kleihauer testing should be done when antenatal anti-D is given following an obstetric event after 20 weeks.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8778974     DOI: 10.1177/003693309403900509

Source DB:  PubMed          Journal:  Scott Med J        ISSN: 0036-9330            Impact factor:   0.729


  3 in total

Review 1.  Anti-D prophylaxis in 1997: the Edinburgh Consensus Statement.

Authors:  D James
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-05       Impact factor: 5.747

2.  Pump up the volume? The routine early use of colloid in very preterm infants.

Authors:  P Hope
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-05       Impact factor: 5.747

Review 3.  Appropriate provision of anti-D prophylaxis to RhD negative pregnant women: a scoping review.

Authors:  Trina M Fyfe; M Jane Ritchey; Christorina Taruc; Daniel Crompton; Brian Galliford; Rose Perrin
Journal:  BMC Pregnancy Childbirth       Date:  2014-12-10       Impact factor: 3.007

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.